- call +1-201-465-4211
- email sales@mrinsights.biz
Anti-aging drugs are used to slow down or reverse the processes of aging to extend the lifespan. Aging, is that damage to the body’s macromolecules, cells, tissues, which is facilitated by genomic instability, epigenetic alterations, loss of proteostasis, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, oxidation damage by free radicals etc
Scope of the Report:
The worldwide market for Anti-Ageing Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the Anti-Ageing Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Nu Skin
BIOTIME
Elysium Health
La Roche-Posay
DermaFix
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Hormonal Therapy
Antioxidants
Enzymes
Stem Cells
Others
Market Segment by Applications, can be divided into
Skin
Hair
Others
There are 15 Chapters to deeply display the global Anti-Ageing Drugs market.
Chapter 1, to describe Anti-Ageing Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Anti-Ageing Drugs, with sales, revenue, and price of Anti-Ageing Drugs, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Anti-Ageing Drugs, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Anti-Ageing Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Anti-Ageing Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Anti-Ageing Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Hormonal Therapy
1.2.2 Antioxidants
1.2.3 Enzymes
1.2.4 Stem Cells
1.2.5 Others
1.3 Market Analysis by Applications
1.3.1 Skin
1.3.2 Hair
1.3.3 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Nu Skin
2.1.1 Business Overview
2.1.2 Anti-Ageing Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Nu Skin Anti-Ageing Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 BIOTIME
2.2.1 Business Overview
2.2.2 Anti-Ageing Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 BIOTIME Anti-Ageing Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Elysium Health
2.3.1 Business Overview
2.3.2 Anti-Ageing Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Elysium Health Anti-Ageing Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 La Roche-Posay
2.4.1 Business Overview
2.4.2 Anti-Ageing Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 La Roche-Posay Anti-Ageing Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 DermaFix
2.5.1 Business Overview
2.5.2 Anti-Ageing Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 DermaFix Anti-Ageing Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Anti-Ageing Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Anti-Ageing Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Anti-Ageing Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Anti-Ageing Drugs Manufacturer Market Share in 2017
3.3.2 Top 6 Anti-Ageing Drugs Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Anti-Ageing Drugs Market Analysis by Regions
4.1 Global Anti-Ageing Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Anti-Ageing Drugs Sales and Market Share by Regions (2013-2018)
4.1.2 Global Anti-Ageing Drugs Revenue and Market Share by Regions (2013-2018)
4.2 North America Anti-Ageing Drugs Sales and Growth Rate (2013-2018)
4.3 Europe Anti-Ageing Drugs Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Anti-Ageing Drugs Sales and Growth Rate (2013-2018)
4.5 South America Anti-Ageing Drugs Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Anti-Ageing Drugs Sales and Growth Rate (2013-2018)
5 North America Anti-Ageing Drugs by Countries
5.1 North America Anti-Ageing Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Anti-Ageing Drugs Sales and Market Share by Countries (2013-2018)
5.1.2 North America Anti-Ageing Drugs Revenue and Market Share by Countries (2013-2018)
5.2 United States Anti-Ageing Drugs Sales and Growth Rate (2013-2018)
5.3 Canada Anti-Ageing Drugs Sales and Growth Rate (2013-2018)
5.4 Mexico Anti-Ageing Drugs Sales and Growth Rate (2013-2018)
6 Europe Anti-Ageing Drugs by Countries
6.1 Europe Anti-Ageing Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Anti-Ageing Drugs Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Anti-Ageing Drugs Revenue and Market Share by Countries (2013-2018)
6.2 Germany Anti-Ageing Drugs Sales and Growth Rate (2013-2018)
6.3 UK Anti-Ageing Drugs Sales and Growth Rate (2013-2018)
6.4 France Anti-Ageing Drugs Sales and Growth Rate (2013-2018)
6.5 Russia Anti-Ageing Drugs Sales and Growth Rate (2013-2018)
6.6 Italy Anti-Ageing Drugs Sales and Growth Rate (2013-2018)
7 Asia-Pacific Anti-Ageing Drugs by Countries
7.1 Asia-Pacific Anti-Ageing Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Anti-Ageing Drugs Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Anti-Ageing Drugs Revenue and Market Share by Countries (2013-2018)
7.2 China Anti-Ageing Drugs Sales and Growth Rate (2013-2018)
7.3 Japan Anti-Ageing Drugs Sales and Growth Rate (2013-2018)
7.4 Korea Anti-Ageing Drugs Sales and Growth Rate (2013-2018)
7.5 India Anti-Ageing Drugs Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Anti-Ageing Drugs Sales and Growth Rate (2013-2018)
8 South America Anti-Ageing Drugs by Countries
8.1 South America Anti-Ageing Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Anti-Ageing Drugs Sales and Market Share by Countries (2013-2018)
8.1.2 South America Anti-Ageing Drugs Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Anti-Ageing Drugs Sales and Growth Rate (2013-2018)
8.3 Argentina Anti-Ageing Drugs Sales and Growth Rate (2013-2018)
8.4 Colombia Anti-Ageing Drugs Sales and Growth Rate (2013-2018)
9 Middle East and Africa Anti-Ageing Drugs by Countries
9.1 Middle East and Africa Anti-Ageing Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Anti-Ageing Drugs Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Anti-Ageing Drugs Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Anti-Ageing Drugs Sales and Growth Rate (2013-2018)
9.3 UAE Anti-Ageing Drugs Sales and Growth Rate (2013-2018)
9.4 Egypt Anti-Ageing Drugs Sales and Growth Rate (2013-2018)
9.5 Nigeria Anti-Ageing Drugs Sales and Growth Rate (2013-2018)
9.6 South Africa Anti-Ageing Drugs Sales and Growth Rate (2013-2018)
10 Global Anti-Ageing Drugs Market Segment by Type
10.1 Global Anti-Ageing Drugs Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Anti-Ageing Drugs Sales and Market Share by Type (2013-2018)
10.1.2 Global Anti-Ageing Drugs Revenue and Market Share by Type (2013-2018)
10.2 Hormonal Therapy Sales Growth and Price
10.2.1 Global Hormonal Therapy Sales Growth (2013-2018)
10.2.2 Global Hormonal Therapy Price (2013-2018)
10.3 Antioxidants Sales Growth and Price
10.3.1 Global Antioxidants Sales Growth (2013-2018)
10.3.2 Global Antioxidants Price (2013-2018)
10.4 Enzymes Sales Growth and Price
10.4.1 Global Enzymes Sales Growth (2013-2018)
10.4.2 Global Enzymes Price (2013-2018)
10.5 Stem Cells Sales Growth and Price
10.5.1 Global Stem Cells Sales Growth (2013-2018)
10.5.2 Global Stem Cells Price (2013-2018)
10.6 Others Sales Growth and Price
10.6.1 Global Others Sales Growth (2013-2018)
10.6.2 Global Others Price (2013-2018)
11 Global Anti-Ageing Drugs Market Segment by Application
11.1 Global Anti-Ageing Drugs Sales Market Share by Application (2013-2018)
11.2 Skin Sales Growth (2013-2018)
11.3 Hair Sales Growth (2013-2018)
11.4 Others Sales Growth (2013-2018)
12 Anti-Ageing Drugs Market Forecast (2018-2023)
12.1 Global Anti-Ageing Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Anti-Ageing Drugs Market Forecast by Regions (2018-2023)
12.2.1 North America Anti-Ageing Drugs Market Forecast (2018-2023)
12.2.2 Europe Anti-Ageing Drugs Market Forecast (2018-2023)
12.2.3 Asia-Pacific Anti-Ageing Drugs Market Forecast (2018-2023)
12.2.4 South America Anti-Ageing Drugs Market Forecast (2018-2023)
12.2.5 Middle East and Africa Anti-Ageing Drugs Market Forecast (2018-2023)
12.3 Anti-Ageing Drugs Market Forecast by Type (2018-2023)
12.3.1 Global Anti-Ageing Drugs Sales Forecast by Type (2018-2023)
12.3.2 Global Anti-Ageing Drugs Market Share Forecast by Type (2018-2023)
12.4 Anti-Ageing Drugs Market Forecast by Application (2018-2023)
12.4.1 Global Anti-Ageing Drugs Sales Forecast by Application (2018-2023)
12.4.2 Global Anti-Ageing Drugs Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Anti-Ageing Drugs Picture
Table Product Specifications of Anti-Ageing Drugs
Figure Global Sales Market Share of Anti-Ageing Drugs by Types in 2017
Table
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
